Postnatal Growth Disorder
6
0
0
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 6 trials
100.0%
+13.5% vs benchmark
17%
1 trials in Phase 3/4
25%
1 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (6)
Physiologic Approach to Sodium Supplementation in Premature Infants
Impact of Electrolyte Intake (Sodium, Phosphorus) on the Growth of Premature Newborns
Target Fortification of Breast Milk: How Often Breast Milk Needs to be Measured?
Individualized Fortification of Breast Milk
Individualized Fortification of Breast Milk for Preterm Infants - A Pilot Study
Early Versus Late Initiation of Feeding in Premature Growth Restricted Newborns With Absent or Reversed End Diastolic Flow On Umbilical Artery Doppler (AREDF)